Hobbyhorses at the Mirus bazaar

417.jpg

Roofies — a street name for the drug flunitrazepam, sold under the brand name Rohypnol — have never been approved for sale in the U.S. A quick glance through some of the other popular street names will give a clue as to why: roaches, mind erasers, ropies, wolfies, forget pills, and the date-rape drug are among the most menacing endearments for the stuff.

The drug was developed in the 1970s by Hoffman LaRoche and began appearing stateside in the 1980s, but the FDA never approved it, not even as a sleep aid, the intention for which it was originally developed. Elsewhere, it’s sold as that or as a hypnotic, which — I don’t even know what to say about living in a country like Sweden, where you could be prescribed a hypnotic. It’s also used to treat hospital patients in preparation for surgery. Here in the U.S., the Safe Streets and Communities Act of 2012 reclassified it a Schedule I drug — one with no medical value whatsoever, like cocaine and heroin.

The side effects of flunitrazepam are what make it such a troubling concoction. In addition to slowing psychomotor performance (e.g., the ability to run away if threatened) and causing whatever combination of relaxation, sedation, and suggestibility, which brings about the designation hypnotic in Europe, the drug also causes memory loss. A standard dosage — one or two milligrams — can last for eight to 12 hours, with hangover effects extending from several days to over a week. It’s also highly addictive. And it can kill you. Although some merely vomit.

Users self-administer roofies as a sleep aid, to enhance the effects of alcohol, or to mitigate depression caused by withdrawal from other drugs. (I’m told it’s a great rush.) Yet flunitrazepam isn’t always self-administered, which is where the mythology that surrounds the stuff is born. It’s been known to have been given to people, unwittingly if not against their will. This is because most who have ingested a standard dosage will exhibit within fifteen minutes a troubling combination of physical docility and compliant suggestibility.

{ Anne Elizabeth Moore/TNI | Continue reading }